KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orasure Technologies (OSUR) Asset Writedowns and Impairment (2018 - 2025)

Historic Asset Writedowns and Impairment for Orasure Technologies (OSUR) over the last 8 years, with Q1 2025 value amounting to -$248000.0.

  • Orasure Technologies' Asset Writedowns and Impairment fell 10742.96% to -$248000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$248000.0, marking a year-over-year decrease of 10321.33%. This contributed to the annual value of $4.4 million for FY2024, which is 5944.22% down from last year.
  • Latest data reveals that Orasure Technologies reported Asset Writedowns and Impairment of -$248000.0 as of Q1 2025, which was down 10742.96% from $1.1 million recorded in Q2 2024.
  • Orasure Technologies' Asset Writedowns and Impairment's 5-year high stood at $10.5 million during Q2 2022, with a 5-year trough of -$1.5 million in Q4 2021.
  • Its 5-year average for Asset Writedowns and Impairment is $2.3 million, with a median of $826000.0 in 2021.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 64050.0% in 2021, then surged by 697516.78% in 2022.
  • Orasure Technologies' Asset Writedowns and Impairment (Quarter) stood at -$1.5 million in 2021, then soared by 542.88% to $6.6 million in 2022, then plummeted by 49.29% to $3.3 million in 2023, then plummeted by 68.31% to $1.1 million in 2024, then tumbled by 123.53% to -$248000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at -$248000.0 for Q1 2025, versus $1.1 million for Q2 2024 and $3.3 million for Q1 2024.